These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 23218158

  • 1. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 2: influence of protocol-specific eligibility criteria on signal detection.
    Sachs GS, Vanderburg DG, Edman S, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov; 73(11):1420-5. PubMed ID: 23218158
    [Abstract] [Full Text] [Related]

  • 2. Adjunctive oral ziprasidone in patients with acute mania treated with lithium or divalproex, part 1: results of a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Vanderburg DG, Karayal ON, Kolluri S, Bachinsky M, Cavus I.
    J Clin Psychiatry; 2012 Nov; 73(11):1412-9. PubMed ID: 23218157
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of adjunctive oral ziprasidone for acute treatment of depression in patients with bipolar I disorder: a randomized, double-blind, placebo-controlled trial.
    Sachs GS, Ice KS, Chappell PB, Schwartz JH, Gurtovaya O, Vanderburg DG, Kasuba B.
    J Clin Psychiatry; 2011 Oct; 72(10):1413-22. PubMed ID: 21672493
    [Abstract] [Full Text] [Related]

  • 4. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N, Mullen J, Paulsson B, Vågerö M.
    J Affect Disord; 2007 Oct; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [Abstract] [Full Text] [Related]

  • 5. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Oct; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 6. A randomized, placebo-controlled, multicenter study of divalproex sodium extended-release in the acute treatment of mania.
    Hirschfeld RM, Bowden CL, Vigna NV, Wozniak P, Collins M.
    J Clin Psychiatry; 2010 Apr; 71(4):426-32. PubMed ID: 20361904
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C, Göğüş A, Grunze H, Häggström L, Rybakowski J, Vieta E.
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [Abstract] [Full Text] [Related]

  • 10. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN, Vieta E, Young AH, Möller HJ, Paulsson B, Vågerö M.
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [Abstract] [Full Text] [Related]

  • 11. Methodologies to avoid the enrollment of ineligible patients in clinical trials.
    Tohen M.
    J Clin Psychiatry; 2012 Nov; 73(11):1426-7. PubMed ID: 23218159
    [No Abstract] [Full Text] [Related]

  • 12. Two 6-week, randomized, double-blind, placebo-controlled studies of ziprasidone in outpatients with bipolar I depression: did baseline characteristics impact trial outcome?
    Lombardo I, Sachs G, Kolluri S, Kremer C, Yang R.
    J Clin Psychopharmacol; 2012 Aug; 32(4):470-8. PubMed ID: 22722504
    [Abstract] [Full Text] [Related]

  • 13. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L, Llorca PM.
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [Abstract] [Full Text] [Related]

  • 14. Rates of remission/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania.
    Ketter TA, Jones M, Paulsson B.
    J Affect Disord; 2007 Apr; 100 Suppl 1():S45-53. PubMed ID: 17383011
    [Abstract] [Full Text] [Related]

  • 15. Allopurinol as an adjunct to lithium and haloperidol for treatment of patients with acute mania: a double-blind, randomized, placebo-controlled trial.
    Akhondzadeh S, Milajerdi MR, Amini H, Tehrani-Doost M.
    Bipolar Disord; 2006 Oct; 8(5 Pt 1):485-9. PubMed ID: 17042886
    [Abstract] [Full Text] [Related]

  • 16. A double-blind, placebo-controlled trial of adjunctive donepezil in treatment-resistant mania.
    Eden Evins A, Demopulos C, Nierenberg A, Culhane MA, Eisner L, Sachs G.
    Bipolar Disord; 2006 Feb; 8(1):75-80. PubMed ID: 16411983
    [Abstract] [Full Text] [Related]

  • 17. Quetiapine in the treatment of acute mania: target dose for efficacious treatment.
    Vieta E, Goldberg JF, Mullen J, Vågerö M, Paulsson B.
    J Affect Disord; 2007 Feb; 100 Suppl 1():S23-31. PubMed ID: 17382403
    [Abstract] [Full Text] [Related]

  • 18. Efficacy of ziprasidone in dysphoric mania: pooled analysis of two double-blind studies.
    Stahl S, Lombardo I, Loebel A, Mandel FS.
    J Affect Disord; 2010 Apr; 122(1-2):39-45. PubMed ID: 19616304
    [Abstract] [Full Text] [Related]

  • 19. Treatment of agitation and aggression in bipolar mania: efficacy of quetiapine.
    Buckley PF, Paulsson B, Brecher M.
    J Affect Disord; 2007 Apr; 100 Suppl 1():S33-43. PubMed ID: 17376537
    [Abstract] [Full Text] [Related]

  • 20. Comparison of two anticonvulsants in a randomized, single-blind treatment of hypomanic symptoms in patients with bipolar disorder.
    Suppes T, Kelly DI, Hynan LS, Snow DE, Sureddi S, Foster B, Curley E.
    Aust N Z J Psychiatry; 2007 May; 41(5):397-402. PubMed ID: 17464731
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.